| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.41B | 21.11B | 19.74B | 19.35B | 19.43B | 18.51B |
| Gross Profit | 6.86B | 7.12B | 6.78B | 6.69B | 6.98B | 6.90B |
| EBITDA | 4.00B | 4.17B | 3.53B | 3.38B | 3.60B | 3.41B |
| Net Income | 2.23B | 2.23B | 2.24B | 2.13B | 2.29B | 2.14B |
Balance Sheet | ||||||
| Total Assets | 20.50B | 20.69B | 19.97B | 18.48B | 17.85B | 17.85B |
| Cash, Cash Equivalents and Short-Term Investments | 1.52B | 1.91B | 2.24B | 2.63B | 2.50B | 2.72B |
| Total Debt | 1.09B | 1.57B | 1.50B | 1.31B | 1.53B | 1.64B |
| Total Liabilities | 5.43B | 5.68B | 5.56B | 5.26B | 5.54B | 5.86B |
| Stockholders Equity | 15.07B | 15.02B | 14.41B | 13.23B | 12.31B | 11.99B |
Cash Flow | ||||||
| Free Cash Flow | 2.47B | 2.60B | 1.83B | 2.01B | 2.24B | 2.22B |
| Operating Cash Flow | 2.76B | 2.88B | 2.12B | 2.33B | 2.57B | 2.50B |
| Investing Cash Flow | -1.03B | -230.00M | -1.65B | -331.00M | -106.00M | -2.16B |
| Financing Cash Flow | -2.21B | -2.27B | -915.00M | -1.61B | -1.94B | -1.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $109.72B | 17.31 | 24.82% | 2.25% | 7.27% | 0.49% | |
73 Outperform | $50.50B | 14.68 | 31.77% | 2.58% | 4.85% | 6.19% | |
71 Outperform | $25.07B | 11.05 | 14.79% | 1.46% | 6.55% | -3.10% | |
68 Neutral | $33.50B | 10.60 | 13.65% | ― | 3.60% | 17.25% | |
66 Neutral | $22.16B | 15.72 | 15.03% | 2.78% | -0.55% | -3.97% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $23.94B | 89.95 | 2.68% | 2.40% | 5.45% | -50.03% |